| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
19,923 |
14,726 |
$1.25M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
5,738 |
5,401 |
$541K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
2,793 |
2,792 |
$263K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
4,865 |
3,780 |
$185K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,741 |
1,737 |
$173K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
1,833 |
1,798 |
$171K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
929 |
929 |
$100K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
4,652 |
4,465 |
$74K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
3,327 |
2,888 |
$59K |
| 90461 |
|
2,411 |
1,222 |
$56K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
4,410 |
4,410 |
$54K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
2,488 |
2,454 |
$51K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,026 |
992 |
$37K |
| H0033 |
Oral medication administration, direct observation |
815 |
797 |
$35K |
| 99188 |
|
1,256 |
1,256 |
$35K |
| 96127 |
|
1,672 |
1,671 |
$26K |
| 87081 |
|
4,363 |
4,200 |
$25K |
| 99173 |
|
1,034 |
1,034 |
$23K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
1,157 |
1,156 |
$23K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
1,267 |
1,241 |
$18K |
| 83655 |
|
1,267 |
1,263 |
$18K |
| 92551 |
|
1,839 |
1,839 |
$17K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,441 |
1,136 |
$17K |
| 99051 |
|
396 |
384 |
$10K |
| 87807 |
|
640 |
620 |
$7K |
| 85027 |
|
428 |
425 |
$6K |
| 94010 |
|
218 |
109 |
$5K |
| V5008 |
Hearing screening |
167 |
167 |
$5K |
| 87430 |
|
344 |
331 |
$4K |
| 99442 |
|
54 |
52 |
$4K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
150 |
131 |
$4K |
| 85018 |
|
1,024 |
1,021 |
$2K |
| 85014 |
|
1,023 |
1,020 |
$2K |
| 87400 |
|
52 |
51 |
$2K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
19 |
19 |
$2K |
| 81000 |
|
441 |
428 |
$2K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
16 |
16 |
$1K |
| 99384 |
|
12 |
12 |
$1K |
| 96160 |
|
522 |
522 |
$1K |
| 99381 |
|
14 |
13 |
$1K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
15 |
15 |
$1K |
| 82465 |
|
85 |
85 |
$1K |
| T1502 |
Administration of oral, intramuscular and/or subcutaneous medication by health care agency/professional, per visit |
40 |
36 |
$1K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
14 |
14 |
$949.55 |
| 81001 |
|
234 |
234 |
$653.70 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
24 |
24 |
$472.64 |
| 96161 |
|
87 |
80 |
$335.82 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
21 |
21 |
$226.59 |
| 92552 |
|
12 |
12 |
$195.72 |
| 94664 |
|
13 |
12 |
$162.96 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
12 |
12 |
$153.93 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
1,155 |
1,134 |
$152.40 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
74 |
72 |
$110.50 |
| 99177 |
|
30 |
30 |
$110.40 |
| 94760 |
|
17 |
17 |
$43.01 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
123 |
122 |
$19.44 |
| 86804 |
|
143 |
140 |
$14.13 |
| 91300 |
|
41 |
40 |
$0.00 |
| 87634 |
|
17 |
16 |
$0.00 |
| 90658 |
|
16 |
16 |
$0.00 |
| 90680 |
|
14 |
14 |
$0.00 |